You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澤璟製藥(688266.SH):A股定增募資規模擬由不超28.63億元降至不超14.55億元
格隆匯 05-19 20:55

格隆匯5月19日丨澤璟製藥(688266.SH)公佈,公司董事會對2021年度向特定對象發行A股股票的發行方案中募集資金規模及用途進行調整。

修訂前:此次發行的募集資金總額不超過人民幣286,285萬元(含本數),扣除發行費用後,183,169萬元用於新藥研發項目,63,116萬元用於新藥研發生產中心三期工程建設項目,4億元用於補充流動資金。

修訂後:此次發行的募集資金總額不超過人民幣145,529萬元(含本數),扣除發行費用後,123,110萬元用於新藥研發項目,22,419萬元用於新藥研發生產中心三期工程建設項目。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account